Sherpath – Tuberculosis Practice Questions and Answers

Sherpath – Tuberculosis Practice Questions and Answers Tuberculosis infectious disease that is a primary cause of death worldwide. It usually involves the lungs, but any organ may be infected. It is the leading cause of mortality in patients with human immunodeficiency virus (HIV) and/or acquired immunodeficiency syndrome (AIDS). Match the type of tuberculosis with the patient symptoms. Blood in the urine Renal Tuberculosis Jaundice and abdominal pain Hepatic Tuberculosis Fever and night sweats Pulmonary Tuberculosis Which situation represents the most risk for spread of tuberculosis? Sitting next to an infected person on an airplane Tuberculosis transmission requires close, frequent, or prolonged airborne exposure, which could be established by sitting next to a person in a confined place like an airplane. An otherwise healthy patient with no history of tuberculosis elicits a significant reaction (Class 2) on a routine tuberculin skin test for employment. The patient asks the nurse what the reaction means. How should the nurse respond to the patient? "You have an inactive TB infection with no sign of the disease." Class 2 is a significant reaction to a tuberculin skin test, no clinical evidence of TB, and TB infection without disease. This person is otherwise healthy with no signs or symptoms, which most closely matches this class of tuberculosis. For which patient would the nurse most likely prepare a Bacille-Calmette-Guerin (BCG) vaccine? A physician caring for TB patients in endemic regions Any health care worker who is continually exposed to patients with TB should receive the BCG vaccine. A patient with acute tuberculosis is treated with INH, rifampin, PZA, and ethambutol for eight weeks. Drug susceptibility testing indicates the bacteria are susceptible to all four drugs. The patient asks the nurse if this means the therapy will change. The nurse explains the patient will likely receive which drugs as a continuous therapy? PZA PZA should be used as continuous therapy when the drug susceptibility test results indicate that the bacteria are susceptible to all drugs. INH INH should be used as continuous therapy when the drug susceptibility test results indicate the bacteria are susceptible to all drugs. Rifampin Rifampin should be used as continuous therapy when the drug susceptibility test results indicate the bacteria are susceptible to all drugs.